Outset Medical Inc
For the period ended Dec 31, 2023. Filed Feb 21, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 21, 2024
OM$4.23+3.2%Stored close · as of Nov 6, 2026
Contents
Statements of Operations
(in thousands, except per share amounts)
| Years Ended December 31, | |||
|---|---|---|---|
| 2023 | 2022 | 2021 | |
| Revenue: | |||
| Product revenue | $103,537 | $93,388 | $84,312 |
| Service and other revenue | 26,839 | 21,987 | 18,290 |
| Total revenue | 130,376 | 115,375 | 102,602 |
| Cost of revenue: | |||
| Cost of product revenue | 74,454 | 82,510 | 84,639 |
| Cost of service and other revenue | 26,922 | 15,032 | 10,355 |
| Total cost of revenue | 101,376 | 97,542 | 94,994 |
| Gross profit | 29,000 | 17,833 | 7,608 |
| Operating expenses: | |||
| Research and development | 57,307 | 48,855 | 36,741 |
| Sales and marketing | 96,232 | 89,482 | 65,070 |
| General and administrative | 45,231 | 40,515 | 36,316 |
| Total operating expenses | 198,770 | 178,852 | 138,127 |
| Loss from operations | (169,770) | (161,019) | (130,519) |
| Interest income and other income, net | 10,171 | 3,291 | 498 |
| Interest expense | (12,675) | (3,566) | (1,715) |
| Loss on extinguishment of term loan | — | (1,367) | — |
| Loss before provision for income taxes | (172,274) | (162,661) | (131,736) |
| Provision for income taxes | 523 | 295 | 199 |
| Net loss | $(172,797) | $(162,956) | $(131,935) |
| Net loss per share, basic and diluted | $(3.48) | $(3.38) | $(2.89) |
| Shares used in computing net loss per share, basic and diluted | 49,588 | 48,161 | $45,589 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.